X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47) 47
hematology (32) 32
adult (29) 29
female (29) 29
index medicus (28) 28
male (24) 24
middle aged (24) 24
oncology (19) 19
transplantation (19) 19
treatment outcome (14) 14
aged (12) 12
chemotherapy (12) 12
adolescent (10) 10
cancer (10) 10
hematopoietic stem cells (10) 10
stem cells (10) 10
hematology, oncology and palliative medicine (9) 9
bone-marrow-transplantation (8) 8
child (8) 8
hematopoietic stem cell transplantation (8) 8
immunology (8) 8
leukemia (8) 8
medicine, general & internal (8) 8
mortality (8) 8
prognosis (8) 8
survival analysis (8) 8
transplantation, homologous (8) 8
young adult (8) 8
disease-free survival (7) 7
follow-up studies (7) 7
health aspects (7) 7
stem-cell transplantation (7) 7
aged, 80 and over (6) 6
analysis (6) 6
hematologic neoplasms - therapy (6) 6
hematopoietic stem cell transplantation - methods (6) 6
peripheral blood stem cell transplantation (6) 6
retrospective studies (6) 6
transplantation conditioning - methods (6) 6
versus-host-disease (6) 6
acute myeloid-leukemia (5) 5
bone marrow (5) 5
care and treatment (5) 5
chronic myelogenous leukemia (5) 5
diagnosis (5) 5
dose-response relationship, drug (5) 5
graft survival (5) 5
hematologic malignancies (5) 5
hematopoietic stem cell transplantation - adverse effects (5) 5
medicine & public health (5) 5
prospective studies (5) 5
research (5) 5
survival (5) 5
survival rate (5) 5
therapy (5) 5
acute myelogenous leukemia (4) 4
acute myeloid leukemia (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
autologous transplantation (4) 4
children (4) 4
cyclophosphamide (4) 4
cyclophosphamide - administration & dosage (4) 4
disease (4) 4
engraftment (4) 4
infectious diseases (4) 4
leukemia, myeloid, acute - pathology (4) 4
medical colleges (4) 4
myelodysplastic syndrome (4) 4
recurrence (4) 4
risk assessment (4) 4
singapore (4) 4
transplantation conditioning (4) 4
transplantation, autologous (4) 4
abridged index medicus (3) 3
age factors (3) 3
allogeneic hematopoietic stem cell transplantation (3) 3
anti-bacterial agents - therapeutic use (3) 3
antifungal agents - therapeutic use (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
asian continental ancestry group (3) 3
bone-marrow transplantation (3) 3
child, preschool (3) 3
chronic myeloid-leukemia (3) 3
cohort studies (3) 3
cord blood stem cell transplantation (3) 3
cord blood stem cell transplantation - adverse effects (3) 3
cytarabine (3) 3
cytarabine - administration & dosage (3) 3
diseases (3) 3
drug resistance (3) 3
drug therapy (3) 3
epidemiology (3) 3
escherichia-coli (3) 3
febrile neutropenia (3) 3
graft vs host disease - prevention & control (3) 3
guidelines (3) 3
hematologic neoplasms - complications (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The American Journal of dermatopathology, ISSN 0193-1091, 08/2019, p. 1
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2017, Volume 23, Issue 3, pp. S199 - S199
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1217 - 1217
Abstract Background Immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine is the preferred treatment for patients with severe... 
Journal Article
Nature Medicine, ISSN 1078-8956, 04/2012, Volume 18, Issue 4, pp. 521 - 528
Tyrosine kinase inhibitors (TKIs) elicit high response rates among individuals with kinase-driven malignancies, including chronic myeloid leukemia (CML) and... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | APOPTOSIS | GEFITINIB | BIOCHEMISTRY & MOLECULAR BIOLOGY | EYE DISEASES | CHRONIC MYELOID-LEUKEMIA | CELL BIOLOGY | CELL LUNG-CANCER | FACTOR RECEPTOR EGFR | GROWTH | ACTIVATING MUTATIONS | MUTANT EGFR | Enzyme-Linked Immunosorbent Assay - methods | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Follow-Up Studies | Apoptosis - drug effects | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | BH3 Interacting Domain Death Agonist Protein - genetics | Dose-Response Relationship, Drug | Protein Isoforms - metabolism | Transfection | Bcl-2-Like Protein 11 | Statistics, Nonparametric | Aged, 80 and over | Apoptosis Regulatory Proteins - genetics | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Lung Neoplasms - genetics | Annexins - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Membrane Proteins - genetics | Gene Frequency | Exons - genetics | Genotype | Proto-Oncogene Proteins - genetics | International Cooperation | Drug Resistance, Neoplasm - genetics | Cell Line, Tumor | Polymorphism, Genetic - genetics | Aged | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Cohort Studies | Drug Resistance, Neoplasm - drug effects | Protein Isoforms - genetics | RNA, Small Interfering - metabolism | Sequence Deletion - genetics | Antimitotic agents | Physiological aspects | Protein tyrosine kinase | Dosage and administration | Genetic aspects | Research | Antineoplastic agents | Tumor proteins | Genetic polymorphisms | Inhibitor drugs | Mutation | Kinases | Gene expression | Apoptosis | Polymorphism
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 01/2015, Volume 162, Issue 2, pp. 81 - 89
Journal Article
Cancer, ISSN 0008-543X, 12/2017, Volume 123, Issue 24, pp. 4851 - 4859
Pracinostat is safe, with modest single‐agent activity reported in patients with hematological malignancies. When combined with azacitidine, pracinostat has... 
acetylation | pracinostat | histone | epigenetic | methylation | Azacitidine - adverse effects | Age Factors | Follow-Up Studies | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Hematologic Neoplasms - pathology | Dose-Response Relationship, Drug | Benzimidazoles - administration & dosage | Neoplasm Invasiveness - pathology | Patient Safety | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Benzimidazoles - adverse effects | Drug Therapy, Combination | Myelodysplastic Syndromes - drug therapy | Azacitidine - administration & dosage | Drug Administration Schedule | Risk Assessment | Leukemia, Myeloid, Acute - pathology | Kaplan-Meier Estimate | Treatment Outcome | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Maximum Tolerated Dose | Myelodysplastic Syndromes - mortality | Sex Factors | Survival Analysis | Hematologic Neoplasms - drug therapy | Aged | Myelodysplastic Syndromes - pathology | Neoplasm Staging | Treatment outcome | Cancer patients | Health aspects | Analysis | Histone deacetylase | Chromatin | Pharmacodynamics | Hematology | Toxicity | Myeloid leukemia | Leukemia | Pharmacology | Tumor cell lines | Patients | Myelodysplastic syndrome | Anticancer properties | Safety engineering | Cell lines | Antitumor activity | Remission | Acetylation | Safety | Solid tumors | Pharmacokinetics | Acute myeloid leukemia | Tumors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 10/2018, Volume 59, Issue 10, pp. 2500 - 2502
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4498 - 4498
Abstract Background:The revised ISS staging system highlights the importance of lactate dehydrogenase (LDH), fluorescence in situ hybridization (FISH) and the... 
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 2015, Volume 2, Issue 2, p. ofv081
Immune suppression is a recognized risk factor for necrotizing fasciitis. In patients with hematological malignancies, a profoundly immunocompromised group,... 
Gram negative | Immunocompromised host | Necrotizing fasciitis | Hematological malignancy | SOFT-TISSUE INFECTIONS | DIAGNOSIS | INFECTIOUS DISEASES | IMPROVEMENT PROGRAM DATABASE | necrotizing fasciitis | OUTCOMES | hematological malignancy | immunocompromised host
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2007, Volume 25, Issue 6, pp. 690 - 697
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 5, pp. 367 - 374
PurposeIncreasing the number of hematopoietic stem and progenitor cells within an umbilical cord blood (UCB) graft shortens the time to hematopoietic recovery... 
TOTAL-BODY IRRADIATION | PROGENITOR CELLS | TRIAL | ACUTE-LEUKEMIA | ENGRAFTMENT | ONCOLOGY | BONE-MARROW | EXPANSION | DISEASE | ADULTS | ORIGINAL REPORTS
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 6, pp. 1008 - 1019
Abstract The successful expansion of hematopoietic stem and progenitor cells (HSPCs) from umbilical cord blood (UCB) for transplantation could revolutionize... 
Hematology, Oncology and Palliative Medicine | Clinical trials | Engraftment | Hematopoietic stem and progenitor cells | Umbilical cord blood | Ex vivo expansion | Hematopoietic stem cell transplantation | Ex vivo expansion | ENHANCE ENGRAFTMENT | MODULATES DIFFERENTIATION | TRANSFERASE VII IMPROVES | BONE-MARROW | UNRELATED DONORS | IMMUNOLOGY | COPPER CHELATOR TETRAETHYLENEPENTAMINE | TRANSPLANTATION | EX-VIVO EXPANSION | CD34(+) CELLS | STEM/PROGENITOR CELLS | GROWTH-FACTOR | HEMATOLOGY | Hematopoietic Stem Cells - drug effects | Intracellular Signaling Peptides and Proteins - pharmacology | Mesenchymal Stromal Cells - drug effects | Stem Cell Niche - immunology | Receptors, Aryl Hydrocarbon - antagonists & inhibitors | Humans | Cells, Cultured | Hematopoietic Stem Cell Transplantation | Clinical Trials as Topic | Membrane Proteins - pharmacology | Ethylenediamines - pharmacology | Cord Blood Stem Cell Transplantation | Mesenchymal Stromal Cells - immunology | Hematopoietic Stem Cells - immunology | Mesenchymal Stromal Cells - cytology | Bioreactors | Hematopoietic Stem Cells - cytology | Insulin-Like Growth Factor Binding Protein 2 - pharmacology | Cell Proliferation - drug effects | Niacinamide - pharmacology | Receptors, Aryl Hydrocarbon - immunology | Cytokines - pharmacology | Niacinamide | Medical colleges | Transplantation | Pharmacy | Hematopoietic stem cells | Stem cells
Journal Article
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 2011, Volume 3, Issue 1, pp. e20110 - e2011014
We report a case of invasive pulmonary aspergillosis (IPA) following respiratory syncytial virus infection in an allogeneic hematopoietic stem cell transplant... 
respiratory syncytial virus | invasive pulmonary aspergillosis | pneumothorax | allogeneic hematopoietic stem cell transplantation
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.